Immunome

$Immunome(IMNM)$ ceo20左右买了好几次了$美国生科ETF-SPDR(XBI)$

$Immunome(IMNM)$ $IDEAYA生物科学(IDYA)$
我很喜欢这种20-30亿市值的肿瘤企业，配置包括一只经验深厚的管理班子，一个10亿左右不大不小的市场的三期完成品种为未来提供稳定现金流再去延伸热门靶点领域做出差异化。

$Nurix Therapeutics(NRIX)$ $Immunome(IMNM)$ 暂时出局。当我购买IMNM时，主要问题是那个三期的读出，但当三期读出后，这两个个股潜在战略冲突。在血液领域，NRIX更强。在实体瘤，肯定是IMNM。但他们相互冲突的管线设计会使我把seagen和NRIX的合作联系起来。虽然，最终的结果会是那样，但是他们还...

$Immunome(IMNM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-26-088172  Act: 34  Size: 18 MB 网页链接

$Immunome(IMNM)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-26-088287  Act: 33  Size: 460 KB 网页链接

$Immunome(IMNM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-26-016437  Act: 34  Size: 11 KB 网页链接

$Immunome(IMNM)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-000422  Act: 34  Size: 7 KB 网页链接

$Immunome(IMNM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001405684-26-000002  Size: 6 KB 网页链接

$Immunome(IMNM)$ 144 Report of proposed sale of securities Accession Number: 0001959173-26-002733  Act: 33  Size: 4 KB 网页链接

$Immunome(IMNM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001221590-26-000003  Size: 6 KB 网页链接

$Immunome(IMNM)$ 144 Report of proposed sale of securities Accession Number: 0001959173-26-002736  Act: 33  Size: 5 KB 网页链接

$Immunome(IMNM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001993684-26-000002  Size: 7 KB 网页链接

$Immunome(IMNM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-26-088141  Act: 34  Size: 374 KB 网页链接

$Immunome(IMNM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001167496-26-000003  Size: 5 KB 网页链接

$Immunome(IMNM)$ 144 Report of proposed sale of securities Accession Number: 0001000275-26-000034  Act: 33  Size: 4 KB 网页链接

$Immunome(IMNM)$ 144/A [Amend] Report of proposed sale of securities Accession Number: 0001959173-26-002775  Act: 33  Size: 5 KB 网页链接